Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

[Current status and future perspective of regenerative medicine for the pancreas].

Mima A, Toyoda T, Osafune K.

Nihon Shokakibyo Gakkai Zasshi. 2018;115(8):681-690. doi: 10.11405/nisshoshi.115.681. Japanese. No abstract available.

PMID:
30101868
2.

Laminin 511 is a target antigen in autoimmune pancreatitis.

Shiokawa M, Kodama Y, Sekiguchi K, Kuwada T, Tomono T, Kuriyama K, Yamazaki H, Morita T, Marui S, Sogabe Y, Kakiuchi N, Matsumori T, Mima A, Nishikawa Y, Ueda T, Tsuda M, Yamauchi Y, Sakuma Y, Maruno T, Uza N, Tsuruyama T, Mimori T, Seno H, Chiba T.

Sci Transl Med. 2018 Aug 8;10(453). pii: eaaq0997. doi: 10.1126/scitranslmed.aaq0997.

PMID:
30089633
3.

Treatment of secondary hyperparathyroidism in patients on hemodialysis using a novel synthetic peptide calcimimetic, etelcalcetide: a short-term clinical study.

Mima A, Tansho K, Nagahara D, Watase K.

J Int Med Res. 2018 Jan 1:300060518786913. doi: 10.1177/0300060518786913. [Epub ahead of print]

PMID:
30027791
4.

Chemokine CXCL16 mediates acinar cell necrosis in cerulein induced acute pancreatitis in mice.

Sakuma Y, Kodama Y, Eguchi T, Uza N, Tsuji Y, Shiokawa M, Maruno T, Kuriyama K, Nishikawa Y, Yamauchi Y, Tsuda M, Ueda T, Matsumori T, Morita T, Tomono T, Kakiuchi N, Mima A, Sogabe Y, Marui S, Kuwada T, Okada A, Watanabe T, Nakase H, Chiba T, Seno H.

Sci Rep. 2018 Jun 11;8(1):8829. doi: 10.1038/s41598-018-27200-y.

5.

Renal protection by sodium-glucose cotransporter 2 inhibitors and its underlying mechanisms in diabetic kidney disease.

Mima A.

J Diabetes Complications. 2018 Jul;32(7):720-725. doi: 10.1016/j.jdiacomp.2018.04.011. Epub 2018 May 5. Review.

PMID:
29880432
6.

Obesity-associated glomerular inflammation increases albuminuria without renal histological changes.

Mima A, Yasuzawa T, King GL, Ueshima S.

FEBS Open Bio. 2018 Feb 26;8(4):664-670. doi: 10.1002/2211-5463.12400. eCollection 2018 Apr.

7.

Collagenous gastritis: a rare disease with distinctive endoscopic findings.

Hayashi S, Nishida T, Adachi S, Mima A, Inada M.

Gastrointest Endosc. 2018 Jul;88(1):186-187. doi: 10.1016/j.gie.2018.02.013. Epub 2018 Feb 21. No abstract available.

PMID:
29476843
8.
9.

Rho-Associated Kinases and Non-muscle Myosin IIs Inhibit the Differentiation of Human iPSCs to Pancreatic Endoderm.

Toyoda T, Kimura A, Tanaka H, Ameku T, Mima A, Hirose Y, Nakamura M, Watanabe A, Osafune K.

Stem Cell Reports. 2017 Aug 8;9(2):419-428. doi: 10.1016/j.stemcr.2017.07.005.

10.

Successful treatment of highly advanced immunoglobulin G4-related kidney disease presenting renal mass-like regions with end-stage kidney failure: a case study.

Ono H, Murakami T, Mima A, Shibata E, Tamaki M, Yoshimoto S, Ueda S, Kishi F, Kishi S, Kawanaka T, Matsuura M, Nagai K, Abe H, Harada M, Doi T.

BMC Nephrol. 2017 Aug 3;18(1):261. doi: 10.1186/s12882-017-0676-5.

11.

Comparable effect of aliskiren or a diuretic added on an angiotensin II receptor blocker on augmentation index in hypertension: a multicentre, prospective, randomised study.

Miyoshi T, Murakami T, Sakuragi S, Doi M, Nanba S, Mima A, Tominaga Y, Oka T, Kajikawa Y, Nakamura K, Ito H.

Open Heart. 2017 Mar 11;4(1):e000591. doi: 10.1136/openhrt-2017-000591. eCollection 2017.

12.

Inflammatory Regulation in Diabetes and Metabolic Dysfunction.

Zhong J, Gong Q, Mima A.

J Diabetes Res. 2017;2017:5165268. doi: 10.1155/2017/5165268. Epub 2017 Mar 15. No abstract available.

13.

Efficacy of mizoribine and prednisolone combination therapy in adult patients with IgA vasculitis.

Mima A.

Rheumatol Int. 2017 Aug;37(8):1387-1393. doi: 10.1007/s00296-017-3685-6. Epub 2017 Mar 2.

PMID:
28255645
14.

Effect of remote ischemia or nicorandil on myocardial injury following percutaneous coronary intervention in patients with stable coronary artery disease: A randomized controlled trial.

Miyoshi T, Ejiri K, Kohno K, Nakahama M, Doi M, Munemasa M, Murakami M, Takaishi A, Kawai Y, Sato T, Sato K, Oka T, Takahashi N, Sakuragi S, Mima A, Enko K, Hosogi S, Nanba S, Hirami R, Nakamura K, Ito H; RINC Study Collaborators.

Int J Cardiol. 2017 Jun 1;236:36-42. doi: 10.1016/j.ijcard.2017.02.028. Epub 2017 Feb 10.

PMID:
28214082
15.

Computed Tomographic Colonography Findings in Ileocecal Tuberculosis.

Iwano T, Nagata K, Mima A, Egawa T, Yamashita H, Saito H.

J Gastrointestin Liver Dis. 2016 Sep;25(3):269. doi: 10.15403/jgld.2014.1121.253.ctc. No abstract available.

16.

Conditional Deletion of Smad1 Ameliorates Glomerular Injury in Progressive Glomerulonephritis.

Araki M, Matsubara T, Abe H, Torikoshi K, Mima A, Iehara N, Fukatsu A, Kita T, Arai H, Doi T.

Sci Rep. 2016 Aug 5;6:31216. doi: 10.1038/srep31216.

17.

Methotrexate induced pneumatosis intestinalis under hemodialysis patient.

Mima A, Nagahara D, Tansho K.

Hemodial Int. 2017 Jan;21(1):E9-E12. doi: 10.1111/hdi.12459. Epub 2016 Jul 5.

PMID:
27381347
18.

Overexpressing IRS1 in Endothelial Cells Enhances Angioblast Differentiation and Wound Healing in Diabetes and Insulin Resistance.

Katagiri S, Park K, Maeda Y, Rao TN, Khamaisi M, Li Q, Yokomizo H, Mima A, Lancerotto L, Wagers A, Orgill DP, King GL.

Diabetes. 2016 Sep;65(9):2760-71. doi: 10.2337/db15-1721. Epub 2016 May 23.

19.

Insulin decreases atherosclerosis by inducing endothelin receptor B expression.

Park K, Mima A, Li Q, Rask-Madsen C, He P, Mizutani K, Katagiri S, Maeda Y, Wu IH, Khamaisi M, Preil SR, Maddaloni E, Sørensen D, Rasmussen LM, Huang PL, King GL.

JCI Insight. 2016 May 5;1(6). pii: e86574.

20.

Pathogenicity of IgG in patients with IgG4-related disease.

Shiokawa M, Kodama Y, Kuriyama K, Yoshimura K, Tomono T, Morita T, Kakiuchi N, Matsumori T, Mima A, Nishikawa Y, Ueda T, Tsuda M, Yamauchi Y, Minami R, Sakuma Y, Ota Y, Maruno T, Kurita A, Sawai Y, Tsuji Y, Uza N, Matsumura K, Watanabe T, Notohara K, Tsuruyama T, Seno H, Chiba T.

Gut. 2016 Aug;65(8):1322-32. doi: 10.1136/gutjnl-2015-310336. Epub 2016 Mar 10.

PMID:
26964842
21.

Incretin-Based Therapy for Prevention of Diabetic Vascular Complications.

Mima A.

J Diabetes Res. 2016;2016:1379274. doi: 10.1155/2016/1379274. Epub 2015 Dec 31. Review.

22.

Spectrum of mutations and genotype-phenotype analysis in Noonan syndrome patients with RIT1 mutations.

Yaoita M, Niihori T, Mizuno S, Okamoto N, Hayashi S, Watanabe A, Yokozawa M, Suzumura H, Nakahara A, Nakano Y, Hokosaki T, Ohmori A, Sawada H, Migita O, Mima A, Lapunzina P, Santos-Simarro F, García-Miñaúr S, Ogata T, Kawame H, Kurosawa K, Ohashi H, Inoue S, Matsubara Y, Kure S, Aoki Y.

Hum Genet. 2016 Feb;135(2):209-22. doi: 10.1007/s00439-015-1627-5. Epub 2015 Dec 29.

PMID:
26714497
23.

[A Case of Rectal Cancer with Portal Vein Tumor Thrombosis Successfully Treated with First-Line Panitumumab Monotherapy].

Takahara B, Mima A, Sasaki K, Mima K.

Gan To Kagaku Ryoho. 2015 Jul;42(7):875-7. Japanese.

PMID:
26197754
24.

Bone Morphogenetic Protein 4 and Smad1 Mediate Extracellular Matrix Production in the Development of Diabetic Nephropathy.

Matsubara T, Araki M, Abe H, Ueda O, Jishage K, Mima A, Goto C, Tominaga T, Kinosaki M, Kishi S, Nagai K, Iehara N, Fukushima N, Kita T, Arai H, Doi T.

Diabetes. 2015 Aug;64(8):2978-90. doi: 10.2337/db14-0893. Epub 2015 May 20.

25.

Gastroesophageal reflux related to respiratory inhibition after crying and feeding hypoxemia in infants.

Minowa H, Tamura R, Mima A, Arai I, Yasuhara H, Ebisu R, Ohgitani A.

J Matern Fetal Neonatal Med. 2016;29(3):512-5. doi: 10.3109/14767058.2015.1009441. Epub 2015 Mar 9.

PMID:
25747946
26.

Respiratory inhibition after crying and feeding hypoxemia in infants.

Minowa H, Hirayama K, Tamura R, Mima A, Ikeda Y, Yasuhara H, Ebisu R, Ohgitani A.

J Matern Fetal Neonatal Med. 2015;28(18):2234-8. doi: 10.3109/14767058.2014.983469. Epub 2014 Nov 27.

PMID:
25363012
27.

Asymmetric intrauterine growth restriction is a risk factor for respiratory inhibition after crying in infants.

Minowa H, Mima A, Ikeda Y, Yasuhara H, Ebisu R, Ohgitani A.

J Matern Fetal Neonatal Med. 2015;28(17):2121-5. doi: 10.3109/14767058.2014.979784. Epub 2014 Nov 14.

PMID:
25347715
28.

Obesity-associated Gingival Vascular Inflammation and Insulin Resistance.

Mizutani K, Park K, Mima A, Katagiri S, King GL.

J Dent Res. 2014 Jun;93(6):596-601. doi: 10.1177/0022034514532102. Epub 2014 Apr 17.

29.

Combat diabetic nephropathy: from pathogenesis to treatment.

Gohda T, Mima A, Moon JY, Kanasaki K.

J Diabetes Res. 2014;2014:207140. doi: 10.1155/2014/207140. Epub 2014 Mar 11. No abstract available.

30.

Polygraphic findings of 47 cases with respiratory inhibition after crying.

Minowa H, Mima A, Ikeda Y, Yasuhara H, Ebisu R, Ohgitani A.

J Matern Fetal Neonatal Med. 2014 Jun;27(9):930-3. doi: 10.3109/14767058.2013.846317. Epub 2013 Oct 11.

PMID:
24117235
31.

Inflammation and oxidative stress in diabetic nephropathy: new insights on its inhibition as new therapeutic targets.

Mima A.

J Diabetes Res. 2013;2013:248563. doi: 10.1155/2013/248563. Epub 2013 Jun 3. Review.

32.

Dual involvement of growth arrest-specific gene 6 in the early phase of human IgA nephropathy.

Nagai K, Miyoshi M, Kake T, Fukushima N, Matsuura M, Shibata E, Yamada S, Yoshikawa K, Kanayama HO, Fukawa T, Yamaguchi K, Izaki H, Mima A, Abe N, Araoka T, Murakami T, Kishi F, Kishi S, Tominaga T, Moriya T, Abe H, Doi T.

PLoS One. 2013 Jun 24;8(6):e66759. doi: 10.1371/journal.pone.0066759. Print 2013.

33.

Serine phosphorylation sites on IRS2 activated by angiotensin II and protein kinase C to induce selective insulin resistance in endothelial cells.

Park K, Li Q, Rask-Madsen C, Mima A, Mizutani K, Winnay J, Maeda Y, D'Aquino K, White MF, Feener EP, King GL.

Mol Cell Biol. 2013 Aug;33(16):3227-41. doi: 10.1128/MCB.00506-13. Epub 2013 Jun 17.

34.

Induction of vascular insulin resistance and endothelin-1 expression and acceleration of atherosclerosis by the overexpression of protein kinase C-β isoform in the endothelium.

Li Q, Park K, Li C, Rask-Madsen C, Mima A, Qi W, Mizutani K, Huang P, King GL.

Circ Res. 2013 Aug 2;113(4):418-27. doi: 10.1161/CIRCRESAHA.113.301074. Epub 2013 Jun 11.

35.

Diabetic nephropathy: protective factors and a new therapeutic paradigm.

Mima A.

J Diabetes Complications. 2013 Sep-Oct;27(5):526-30. doi: 10.1016/j.jdiacomp.2013.03.003. Epub 2013 Apr 22. Review.

PMID:
23619194
36.

Use of a polysulfone hemodialysis membrane may prevent recurrent posterior reversible encephalopathy syndrome in a patient undergoing hemodialysis.

Mima A, Matsubara T, Endo S, Murakami T, Hashimoto Y.

Int Urol Nephrol. 2014 Jan;46(1):255-60. doi: 10.1007/s11255-013-0434-y. Epub 2013 Apr 9.

PMID:
23568662
37.

Retinal not systemic oxidative and inflammatory stress correlated with VEGF expression in rodent models of insulin resistance and diabetes.

Mima A, Qi W, Hiraoka-Yamomoto J, Park K, Matsumoto M, Kitada M, Li Q, Mizutani K, Yu E, Shimada T, Lee J, Shoelson SE, Jobin C, Rask-Madsen C, King GL.

Invest Ophthalmol Vis Sci. 2012 Dec 19;53(13):8424-32. doi: 10.1167/iovs.12-10207.

38.

Implications of treatment that target protective mechanisms against diabetic nephropathy.

Mima A, Qi W, King GL.

Semin Nephrol. 2012 Sep;32(5):471-8. doi: 10.1016/j.semnephrol.2012.07.010. Review.

39.

Acute glomerulonephritis in an immunocompetent elderly woman after contact with a child who had been diagnosed as erythema infectiosum.

Kishi S, Yamada S, Kishi F, Shibata E, Matsuura M, Nagai K, Mima A, Abe H, Doi T.

Intern Med. 2012;51(16):2197-201. Epub 2012 Aug 15.

40.

Protein inhibitor of activated STAT, PIASy regulates α-smooth muscle actin expression by interacting with E12 in mesangial cells.

Torikoshi K, Abe H, Matsubara T, Hirano T, Ohshima T, Murakami T, Araki M, Mima A, Iehara N, Fukatsu A, Kita T, Arai H, Doi T.

PLoS One. 2012;7(7):e41186. doi: 10.1371/journal.pone.0041186. Epub 2012 Jul 19.

41.

Protective effects of GLP-1 on glomerular endothelium and its inhibition by PKCβ activation in diabetes.

Mima A, Hiraoka-Yamomoto J, Li Q, Kitada M, Li C, Geraldes P, Matsumoto M, Mizutani K, Park K, Cahill C, Nishikawa S, Rask-Madsen C, King GL.

Diabetes. 2012 Nov;61(11):2967-79. doi: 10.2337/db11-1824. Epub 2012 Jul 23.

42.

Hemodialysis vascular access dysfunction: molecular mechanisms and treatment.

Mima A.

Ther Apher Dial. 2012 Aug;16(4):321-7. doi: 10.1111/j.1744-9987.2012.01066.x. Epub 2012 Apr 2. Review.

PMID:
22817119
43.

[CT enterography with polyethylene glycol electrolyte solution for diagnosis of Crohn's disease].

Ohana M, Mima A, Sonoyama H, Kikuchi S, Okabe M, Morisawa T, Shio S, Miyajima S, Kida H, Okano A, Okinaga S, Kusumi F, Nabeshima M.

Nihon Shokakibyo Gakkai Zasshi. 2012 Jun;109(6):910-20. Japanese.

PMID:
22688167
44.

Glomerular VEGF resistance induced by PKCδ/SHP-1 activation and contribution to diabetic nephropathy.

Mima A, Kitada M, Geraldes P, Li Q, Matsumoto M, Mizutani K, Qi W, Li C, Leitges M, Rask-Madsen C, King GL.

FASEB J. 2012 Jul;26(7):2963-74. doi: 10.1096/fj.11-202994. Epub 2012 Apr 12.

45.

Comparison of the psychosocial quality of life in hemodialysis patients between the elderly and non-elderly using a visual analogue scale: the importance of appetite and depressive mood.

Kanamori H, Nagai K, Matsubara T, Mima A, Yanagita M, Iehara N, Takechi H, Fujimaki K, Usami K, Fukatsu A, Kita T, Matsubayashi K, Arai H.

Geriatr Gerontol Int. 2012 Jan;12(1):65-71. doi: 10.1111/j.1447-0594.2011.00731.x. Epub 2011 Aug 15.

PMID:
21843200
46.

SOX9 protein induces a chondrogenic phenotype of mesangial cells and contributes to advanced diabetic nephropathy.

Kishi S, Abe H, Akiyama H, Tominaga T, Murakami T, Mima A, Nagai K, Kishi F, Matsuura M, Matsubara T, Iehara N, Ueda O, Fukushima N, Jishage K, Doi T.

J Biol Chem. 2011 Sep 16;286(37):32162-9. doi: 10.1074/jbc.M111.244541. Epub 2011 Jul 27.

47.

An autopsy case of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) with intestinal bleeding in chronic renal failure.

Mima A, Shiota F, Matsubara T, Iehara N, Akagi T, Abe H, Nagai K, Matsuura M, Murakami T, Kishi S, Araoka T, Kishi F, Kondo N, Shigeta R, Yoshikawa K, Kita T, Doi T, Fukatsu A.

Ren Fail. 2011;33(6):622-5. doi: 10.3109/0886022X.2011.585730. Epub 2011 Jun 1.

PMID:
21631236
48.

MPO-ANCA-positive anti-glomerular basement membrane antibody disease successfully treated by plasma exchange and immunosuppressive therapy.

Murakami T, Nagai K, Matsuura M, Kondo N, Kishi S, Araoka T, Kishi F, Sakiyama T, Mima A, Bando Y, Abe H, Doi T.

Ren Fail. 2011;33(6):626-31. doi: 10.3109/0886022X.2011.581401. Epub 2011 May 20.

PMID:
21599422
49.

Activation of bone morphogenetic protein 4 signaling leads to glomerulosclerosis that mimics diabetic nephropathy.

Tominaga T, Abe H, Ueda O, Goto C, Nakahara K, Murakami T, Matsubara T, Mima A, Nagai K, Araoka T, Kishi S, Fukushima N, Jishage K, Doi T.

J Biol Chem. 2011 Jun 3;286(22):20109-16. doi: 10.1074/jbc.M110.179382. Epub 2011 Apr 6.

50.

Activation of Src mediates PDGF-induced Smad1 phosphorylation and contributes to the progression of glomerulosclerosis in glomerulonephritis.

Mima A, Abe H, Nagai K, Arai H, Matsubara T, Araki M, Torikoshi K, Tominaga T, Iehara N, Fukatsu A, Kita T, Doi T.

PLoS One. 2011 Mar 22;6(3):e17929. doi: 10.1371/journal.pone.0017929.

Supplemental Content

Support Center